Study of thyroid profile in seropositive HIV adults patients on HAART regimen
DOI:
https://doi.org/10.18203/2349-3933.ijam20173238Keywords:
HAART, HIV, Thyroid, Overt hypothyroidism, Sub clinical hypothyroidismAbstract
Background: Subtle alterations in thyroid function tests are more common in HIV infection and at times detectable in the early phase of disease and as well as in late phases. However, there is paucity of Indian studies.
Methods: This cross-sectional study was carried out among adult HIV positive patients attending OPD and IPD of tertiary care hospital in collaboration with ART-plus center over a period of 21months. 100 adult HIV positive patients were interviewed and clinically examined. On the basis of CD4 count patients were divided into 3 groups {0-200 (Group A), 201-350 (Group B) and >350 cells/mm3 (Group C)}. Subjects were also divided into two group based on type and duration of HAART regimen.
Results: Out of 100 patients included in the study 68% were males, 73% married, 12% had subclinical hypothyroidism, out of 6% of overt hypothyroidism subjects 5% were females. Among the 3 groups, thyroid abnormalities were found to be more common in group B followed by Group A and C. Patients on TLE regimen had 14% thyroid abnormalities as compared to 4% in ZLN group.
Conclusions: Subclinical hypothyroidism and overt hypothyroidism are the commonest thyroid abnormality seen, more commonly in females. CD4 counts have direct association with free T3 and free T4 and inverse association with Serum TSH level indicating trend for hypothyroidism as HIV disease progresses. Thyroid abnormalities vary with the type and duration of HAART regimen.
References
UNAIDS (2014) 'The Gap Report.' Available at www.unaids.org/en/resources/documents/2014/20140716_UNAIDS_gap_report.
Goddard GZ, Shoenfeld Y. HIV and autoimmunity: Autoimmunity Reviews. 2002;1:329-37.
Yogesh Shukla, Rohit BK. Sociodemographic profile of people living with HIV/AIDS attending ART center in a tertiary-care hospital in central India: Int J Med Sci Public Health. 2015;4(10):1464-7.
Grappin M, Piroth L, Verges B, Sgro C, Mack G, Buisson M, et al. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. Aids. 2000;14(8):1070.
Meena LP, Rai M, Singh SK, Chakravarthy J, Singh A, Goel R, et al. Endocrine changes in male HIV patients. JAPI:2011:59:13.
Beltran S, Lescure FX, Desailloud R, Douadi Y, Smail A, El Esper I, et al. Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: A need for screening. Clinical Infectious Diseases. 2003:579-83.
Madge S, Smith CJ, Lampe FC, Thomas M, Johnson MA, Youle M, et al. No association between HIV disease and its treatment and thyroid function. HIV Med. 2007;8(1):22-7.
Varthakavi PK: Thyroid dysfunction in HIV-AIDS. J Assoc Physicians Ind. 2009;57:503-4.
Mandal SK, Paul R, Bandyopadhyay D, Basu AK, Mandal L. Study on endocrine profile of HIV infected male patients. Int Res J Pharm. 2013;4:220-3.
Sharma N, Sharma LK, Dutta D, Gadpayle AK, Anand A, Gaurav K, et al. Prevalence and predictors of thyroid dysfunction in patients with HIV infection and acquired immunodeficiency syndrome: An Indian perspective. J Thyroid Res. 2015;2015.
Tripathy SK, Agrawala RK. Endocrine alterations in HIV-infected patients: 2015;19(1):143-7.
Jain G, Devpura G, Gupta BS. Abnormalities in the thyroid function tests as surrogate marker of advancing HIV infection in infected adults. JAPI. 2009;57:508-10.
Pasupathi P, Manivannan P, Manivannan U, Deepa M. Thyroid function, cardiac risk assessment profile and hematological changes during HIV infection and AIDS patients. J Med. 2010;11(2):131-6.
Thongam S, Keithelakpam S, Singh TY, Singh RL, Singh AM, Ranabir S. Thyroid dysfunction in human immunodeficiency virus-infected children and its correlation with CD4+ T lymphocyte count. Ind J Endocrinol Metabol, vol. 2015;19(2):272-6.
Raffi F, Brisseau JM, Planchon B, Rémi JP, Barrier JH, Grolleau JY. Endocrine function in 98 HIV-infected patients: a prospective study. AIDS. 1991;5(6):729-34.
Dev N, Sahoo R, Kulshreshtha B, Gadpayle AK. Int J STD AIDS. 2015;26(13):965-70.
Ji S, Jin C, Höxtermann S, Fuchs W, Xie T, Lu X, et al. Prevalence and influencing factors of thyroid dysfunction in HIV-infected patients. Bio Med Res International. 2016;2016.
